<DOC>
	<DOCNO>NCT00592098</DOCNO>
	<brief_summary>The objective study investigate analgesic effect topical strontium chloride stump pain , prospectively determine efficacy safety measure topical strontium chloride stump pain .</brief_summary>
	<brief_title>2PX ( Topical Strontium Chloride Hexahydrate ) Patients With Post-Amputation Stump Pain .</brief_title>
	<detailed_description />
	<criteria>Lower limb amputation least 6 month prior inclusion Presenting moderatetosevere pain intensity ( 50 100 mm VAS ) screening , confirm prior randomisation : Mean ( 14 day runin period ) stump API rating 50 100 mm VAS Outpatients , age 18 year Written inform consent Subjects receive treatment potent opioid 4 week prior study entry ( i.e . opioid assume cause abstinence symptom upon abrupt cessation ) Subjects take analgesic medication ( except rescue medication define protocol ) Subjects express dissatisfaction prosthesis comfort Pregnant breastfeed woman Any malignant disease Subjects receive investigational drug use investigational device 30 day prior study entry . Subjects unable comply study assessment Subjects document suspected alcohol drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Lower limb amputation least 6 month prior inclusion</keyword>
	<keyword>Presenting moderate-to-severe pain intensity</keyword>
	<keyword>Outpatients , age 18 year</keyword>
</DOC>